Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity.
Immunity. 2022 Jul 12;55(7):1268-1283.e9. doi: 10.1016/j.immuni.2022.05.012. Epub 2022 Jun 13.
Immunity. 2022.
PMID: 35700739